A markedly reduced-laxative CT colonography: a radormized clinical trial

A markedly reduced-laxative CT colonography: a radormized clinical trial - Reduced-laxative CTC Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022851

Enrollment

Registered

2016-07-01

Start date

2016-06-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal disease

Interventions

total dose of MoviPrep 400ml total dose of MoviPrep 600ml total dose of MoviPrep 800ml

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suspicious for colorectal diseases, who need colon screening test

Exclusion criteria

Exclusion criteria: Inflammatory bowel disease, familial adenomatous polyposis, Lynch syndrome, history of bowel resection, GI tract stenosis obstruction or perforation, toxic megacolon. High risk for bowel preparation or CT colonography, pregnancy or its possibility, psychiatric disease or symptom, claustrophobia, serious iodine allergy, thyroidal disease, and others

Design outcomes

Primary

Measure	Time frame
Quality of bowel preparation for CT colonography (size of residual feces, volume of residual liquid, quality of fecal tagging)	—

Secondary

Measure	Time frame
patient acceptability	—

Countries

Japan

Contacts

Public ContactKenichi Utano

Fukushima Medical University Aizu Medical Center

k-utano@fmu.ac.jp+81-242752100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026